California Proxy Statement and Prospectus with Exhibits for WHO Corp. provides detailed information and disclosure regarding the operations, finances, and governance of WHO Corp., a California-based corporation. This document serves as an important communication tool for shareholders and potential investors, aiding them in making informed decisions about their investment in WHO Corp. Keywords: California Proxy Statement, Prospectus, WHO Corp., exhibits, shareholders, investors, operations, finances, governance, communication, investment. The California Proxy Statement and Prospectus for WHO Corp. contains several exhibits that further enhance the information provided. These exhibits may include: 1. Financial Statements: This exhibit includes audited financial information, such as balance sheets, income statements, and cash flow statements. It provides a comprehensive overview of WHO Corp.'s financial performance and helps investors assess the company's profitability and stability. 2. Management Discussion and Analysis (MDA): This exhibit provides an in-depth analysis of WHO Corp.'s financial condition, results of operations, and future prospects. It helps investors understand the factors influencing the company's performance and potential risks and uncertainties. 3. Corporate Governance Guidelines: This exhibit outlines the principles and practices that WHO Corp. follows to ensure effective corporate governance. It includes information about the structure of the board of directors, committees, and policies related to board independence, ethical conduct, executive compensation, and shareholder rights. 4. Executive Compensation: This exhibit discloses details about the compensation packages of WHO Corp.'s executives, including salaries, bonuses, stock options, and other benefits. It helps shareholders assess whether executive compensation aligns with the company's performance and shareholder interests. 5. Shareholder Voting Matters: This exhibit provides information on matters to be voted upon by shareholders, such as board elections, approval of significant transactions, or amendments to corporate bylaws. It includes details on how shareholders can cast their votes and participate in the decision-making process. 6. Risk Factors: This exhibit highlights the potential risks and uncertainties that may affect WHO Corp.'s business, financial condition, and future performance. It helps investors understand the specific challenges and external factors that could impact their investment. These various types of exhibits within the California Proxy Statement and Prospectus for WHO Corp. ensure that shareholders and potential investors have access to comprehensive and transparent information when considering their involvement with the company.